应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ESPR Esperion Therapeutics Inc.
盘后交易 10-10 18:45:56 EDT
2.53
+0.08
+3.05%
盘后
2.51
-0.02
-0.79%
18:28 EDT
最高
2.59
最低
2.44
成交量
753.45万
今开
2.46
昨收
2.46
日振幅
6.11%
总市值
5.86亿
流通市值
5.82亿
总股本
2.32亿
成交额
1,885万
换手率
3.28%
流通股本
2.30亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Esperion Therapeutics股价盘后下跌17%至2.55美元,此前公司宣布拟发行股票
美股速递 · 10-07
Esperion Therapeutics股价盘后下跌17%至2.55美元,此前公司宣布拟发行股票
Esperion Therapeutics针对Alkem、Aurobindo Pharma、Msn、Renata、Sandoz的专利诉讼仍在进行中
美股速递 · 10-03
Esperion Therapeutics针对Alkem、Aurobindo Pharma、Msn、Renata、Sandoz的专利诉讼仍在进行中
Esperion Therapeutics Inc.与Anda Filer、DR. Reddy's Laboratories达成和解协议,后者承诺在2040年4月19日前不销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)仿制药
美股速递 · 10-03
Esperion Therapeutics Inc.与Anda Filer、DR. Reddy's Laboratories达成和解协议,后者承诺在2040年4月19日前不销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)仿制药
Esperion Therapeutics Inc.合作伙伴Otsuka获得日本监管批准,可销售Nexletol®用于治疗高胆固醇血症
美股速递 · 09-19
Esperion Therapeutics Inc.合作伙伴Otsuka获得日本监管批准,可销售Nexletol®用于治疗高胆固醇血症
Esperion Therapeutics Inc. 贝培度酸获推荐用于无法接受他汀类药物治疗以达成LDL-C目标的患者,推荐等级为I类B级
美股速递 · 08-29
Esperion Therapeutics Inc. 贝培度酸获推荐用于无法接受他汀类药物治疗以达成LDL-C目标的患者,推荐等级为I类B级
Esperion Therapeutics的贝美前列酸在最新ESC/EAS血脂异常管理指南中获得1a级推荐
美股速递 · 08-29
Esperion Therapeutics的贝美前列酸在最新ESC/EAS血脂异常管理指南中获得1a级推荐
Esperion Therapeutics, Inc.盘中异动 大幅下跌5.03%
市场透视 · 05-22
Esperion Therapeutics, Inc.盘中异动 大幅下跌5.03%
Esperion Therapeutics, Inc.盘中异动 快速下跌5.28%报0.861美元
市场透视 · 05-21
Esperion Therapeutics, Inc.盘中异动 快速下跌5.28%报0.861美元
Esperion Therapeutics, Inc.盘中异动 早盘股价大涨5.31%报0.910美元
市场透视 · 05-20
Esperion Therapeutics, Inc.盘中异动 早盘股价大涨5.31%报0.910美元
Esperion Therapeutics, Inc.盘中异动 早盘快速上涨5.01%报0.842美元
市场透视 · 05-19
Esperion Therapeutics, Inc.盘中异动 早盘快速上涨5.01%报0.842美元
Esperion Therapeutics, Inc.盘中异动 早盘急速下跌5.07%
市场透视 · 05-15
Esperion Therapeutics, Inc.盘中异动 早盘急速下跌5.07%
Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%
市场透视 · 05-14
Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%
Esperion Therapeutics, Inc.盘中异动 股价大涨5.06%
市场透视 · 05-12
Esperion Therapeutics, Inc.盘中异动 股价大涨5.06%
Esperion Therapeutics, Inc.2025财年第一财季实现净利润-40.46百万美元,同比减少166.31%
市场透视 · 05-11
Esperion Therapeutics, Inc.2025财年第一财季实现净利润-40.46百万美元,同比减少166.31%
Esperion Therapeutics, Inc.盘中异动 早盘急速拉升5.16%报0.916美元
市场透视 · 05-08
Esperion Therapeutics, Inc.盘中异动 早盘急速拉升5.16%报0.916美元
Needham:维持Esperion Therapeutics评级,由买入调整至买入评级, 目标价由5.00美元调整至4.00美元。
金融界 · 05-07
Needham:维持Esperion Therapeutics评级,由买入调整至买入评级, 目标价由5.00美元调整至4.00美元。
Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%报1.04美元
市场透视 · 05-05
Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%报1.04美元
Esperion Therapeutics, Inc.盘中异动 早盘急速上涨5.06%报1.050美元
市场透视 · 05-01
Esperion Therapeutics, Inc.盘中异动 早盘急速上涨5.06%报1.050美元
Esperion Therapeutics, Inc.盘中异动 急速拉升5.22%报1.010美元
市场透视 · 04-30
Esperion Therapeutics, Inc.盘中异动 急速拉升5.22%报1.010美元
Esperion Therapeutics, Inc.盘中异动 大幅拉升5.10%
市场透视 · 04-29
Esperion Therapeutics, Inc.盘中异动 大幅拉升5.10%
加载更多
公司概况
公司名称:
Esperion Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Esperion Therapeutics, Inc.于2008年1月在特拉华州注册成立。该公司是一家后期制药公司,专注于开发和商业化补充,方便,具有成本效益的每日一次口服疗法,用于治疗 LDL-C升高的患者。 通过科学和临床卓越以及对胆固醇生物学的深入理解,该公司有经验的脂质管理团队致力于开发新的LDL-C降低疗法,这将对减少全球心血管疾病或心血管疾病产生重大影响; 世界各地死亡的主要原因。
发行价格:
--
{"stockData":{"symbol":"ESPR","market":"US","secType":"STK","nameCN":"Esperion Therapeutics Inc.","latestPrice":2.53,"timestamp":1760126400000,"preClose":2.455,"halted":0,"volume":7534455,"hourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.53,"latestTime":"18:28 EDT","volume":92254,"amount":230047.2682168,"timestamp":1760135304382},"delay":0,"floatShares":229999999,"shares":231622825,"eps":-0.530482,"marketStatus":"盘后交易","change":0.075,"latestTime":"10-10 18:45:56 EDT","open":2.46,"high":2.59,"low":2.44,"amount":18853862.3053875,"amplitude":0.0611,"askPrice":2.51,"askSize":20,"bidPrice":2.4,"bidSize":7131,"shortable":3,"etf":0,"ttmEps":-0.530482,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1760140800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1372219200000,"exchange":"NASDAQ","adjPreClose":2.455,"preHourTrading":{"tag":"盘前","latestPrice":2.46,"preClose":2.455,"latestTime":"09:29 EDT","volume":30998,"amount":76493.3802248,"timestamp":1760102999999},"postHourTrading":{"tag":"盘后","latestPrice":2.51,"preClose":2.53,"latestTime":"18:28 EDT","volume":92254,"amount":230047.2682168,"timestamp":1760135304382},"volumeRatio":0.516334,"impliedVol":0.698,"impliedVolPercentile":0.356},"requestUrl":"/m/hq/s/ESPR","defaultTab":"news","newsList":[{"id":"1102999674","title":"Esperion Therapeutics股价盘后下跌17%至2.55美元,此前公司宣布拟发行股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1102999674","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102999674?lang=zh_cn&edition=full","pubTime":"2025-10-08 04:36","pubTimestamp":1759869382,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics股价盘后下跌17%至2.55美元,此前公司宣布拟发行股票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ESPR"],"gpt_icon":0},{"id":"1174936842","title":"Esperion Therapeutics针对Alkem、Aurobindo Pharma、Msn、Renata、Sandoz的专利诉讼仍在进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=1174936842","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174936842?lang=zh_cn&edition=full","pubTime":"2025-10-03 20:03","pubTimestamp":1759492995,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics针对Alkem、Aurobindo Pharma、Msn、Renata、Sandoz的专利诉讼仍在进行中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ESPR"],"gpt_icon":0},{"id":"1164272152","title":"Esperion Therapeutics Inc.与Anda Filer、DR. Reddy's Laboratories达成和解协议,后者承诺在2040年4月19日前不销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1164272152","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164272152?lang=zh_cn&edition=full","pubTime":"2025-10-03 20:01","pubTimestamp":1759492885,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics Inc.宣布与Anda Filer和DR. Reddy's Laboratories达成和解协议。根据协议条款,这两家公司承诺在2040年4月19日之前不会销售Nexletol®(贝前列酸)和Nexlizet®(贝前列酸和依折麦布)的仿制药版本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","BK4007"],"gpt_icon":0},{"id":"1115093991","title":"Esperion Therapeutics Inc.合作伙伴Otsuka获得日本监管批准,可销售Nexletol®用于治疗高胆固醇血症","url":"https://stock-news.laohu8.com/highlight/detail?id=1115093991","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115093991?lang=zh_cn&edition=full","pubTime":"2025-09-19 20:01","pubTimestamp":1758283318,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics Inc.的合作伙伴Otsuka已获得日本监管部门批准,可在日本市场销售Nexletol®,用于治疗高胆固醇血症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","BK4007"],"gpt_icon":0},{"id":"1135418780","title":"Esperion Therapeutics Inc. 贝培度酸获推荐用于无法接受他汀类药物治疗以达成LDL-C目标的患者,推荐等级为I类B级","url":"https://stock-news.laohu8.com/highlight/detail?id=1135418780","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135418780?lang=zh_cn&edition=full","pubTime":"2025-08-29 20:05","pubTimestamp":1756469159,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics Inc. 贝培度酸获得推荐,用于无法接受他汀类药物治疗以达成低密度脂蛋白胆固醇(LDL-C)目标的患者群体。该推荐等级为I类B级。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","BK4007"],"gpt_icon":0},{"id":"1151843361","title":"Esperion Therapeutics的贝美前列酸在最新ESC/EAS血脂异常管理指南中获得1a级推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=1151843361","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151843361?lang=zh_cn&edition=full","pubTime":"2025-08-29 20:03","pubTimestamp":1756469039,"startTime":"0","endTime":"0","summary":"Esperion Therapeutics Inc.宣布,其贝美前列酸药物在最新更新的欧洲心脏病学会/欧洲动脉粥样硬化学会(ESC/EAS)血脂异常管理指南中获得了1a级推荐。这一推荐等级代表了该药物在血脂异常治疗领域的重要地位和临床价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESPR","BK4007"],"gpt_icon":0},{"id":"2537742944","title":"Esperion Therapeutics, Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537742944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537742944?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:39","pubTimestamp":1747921141,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时39分,Esperion Therapeutics, Inc.股票出现异动,股价急速下挫5.03%。截至发稿,该股报0.810美元/股,成交量18.5349万股,换手率0.09%,振幅5.84%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.81%。其相关个股中,Inmed Pharmaceuticals Inc.、Medicus Pharma Ltd.、Alpha Teknova, Inc.涨幅较大,Incannex Healthcare Inc.、Canopy Growth Corporation、Quantum Biopharma Ltd.较为活跃,换手率分别为18.15%、2.81%、1.27%,振幅较大的相关个股有Quantum Biopharma Ltd.、Medicus Pharma Ltd.、Esperion Therapeutics, Inc.,振幅分别为11.06%、7.91%、7.00%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213901a6e8f37c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213901a6e8f37c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ","ESPR"],"gpt_icon":0},{"id":"2537304379","title":"Esperion Therapeutics, Inc.盘中异动 快速下跌5.28%报0.861美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537304379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537304379?lang=zh_cn&edition=full","pubTime":"2025-05-22 00:32","pubTimestamp":1747845169,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日00时32分,Esperion Therapeutics, Inc.股票出现异动,股价快速下跌5.28%。截至发稿,该股报0.861美元/股,成交量188.391万股,换手率0.95%,振幅6.18%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.57%。其相关个股中,Quantum Biopharma Ltd.、Gelteq Limited、苏轩堂涨幅较大,Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.、Cbdmd, Inc.较为活跃,换手率分别为11184.27%、52.27%、10.00%,振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、脑再生科技、Petros Pharmaceuticals, Inc.,振幅分别为24.16%、19.79%、18.15%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052200325094fe26c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052200325094fe26c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","ESPR","LENZ"],"gpt_icon":0},{"id":"2536646827","title":"Esperion Therapeutics, Inc.盘中异动 早盘股价大涨5.31%报0.910美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536646827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536646827?lang=zh_cn&edition=full","pubTime":"2025-05-20 22:28","pubTimestamp":1747751287,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日22时28分,Esperion Therapeutics, Inc.股票出现异动,股价急速拉升5.31%。截至发稿,该股报0.910美元/股,成交量84.203万股,换手率0.42%,振幅5.75%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.05%。其相关个股中,脑再生科技、Scilex Holding Company、Incannex Healthcare Inc.涨幅较大,Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.、大自然药业较为活跃,换手率分别为282.44%、259.97%、6.14%,振幅较大的相关个股有脑再生科技、Incannex Healthcare Inc.、Scilex Holding Company,振幅分别为22.51%、20.01%、13.74%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520222807a4858a37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520222807a4858a37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","ESPR"],"gpt_icon":0},{"id":"2536386756","title":"Esperion Therapeutics, Inc.盘中异动 早盘快速上涨5.01%报0.842美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536386756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536386756?lang=zh_cn&edition=full","pubTime":"2025-05-19 22:14","pubTimestamp":1747664042,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日22时14分,Esperion Therapeutics, Inc.股票出现异动,股价急速上涨5.01%。截至发稿,该股报0.842美元/股,成交量69.9872万股,换手率0.35%,振幅5.05%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体跌幅为0.40%。其相关个股中,苏轩堂、Quantum Biopharma Ltd.、正业生物涨幅较大,Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.、苏轩堂较为活跃,换手率分别为110.00%、80.57%、44.22%,振幅较大的相关个股有Scilex Holding Company C/Wts 10/11/2027 、苏轩堂、脑再生科技,振幅分别为23.89%、23.34%、22.37%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922140294fb9b87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051922140294fb9b87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","LENZ","ESPR","BK4139"],"gpt_icon":0},{"id":"2535827556","title":"Esperion Therapeutics, Inc.盘中异动 早盘急速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535827556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535827556?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:46","pubTimestamp":1747320361,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时46分,Esperion Therapeutics, Inc.股票出现波动,股价急速下跌5.07%。截至发稿,该股报0.693美元/股,成交量194.981万股,换手率0.98%,振幅6.59%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.15%。其相关个股中,Aytu Biopharma, Inc.、Journey Medical Corporation、Scilex Holding Company C/Wts 10/11/2027 涨幅较大,Petros Pharmaceuticals, Inc.、Aytu Biopharma, Inc.、Incannex Healthcare Inc.较为活跃,换手率分别为3546.25%、425.34%、306.90%,振幅较大的相关个股有Journey Medical Corporation、Petros Pharmaceuticals, Inc.、Aytu Biopharma, Inc.,振幅分别为33.84%、29.93%、28.89%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224602a47fb882&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515224602a47fb882&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4139","BK4007","ESPR"],"gpt_icon":0},{"id":"2535078436","title":"Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535078436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535078436?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:48","pubTimestamp":1747230530,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时48分,Esperion Therapeutics, Inc.股票出现波动,股价急速下挫5.05%。截至发稿,该股报0.741美元/股,成交量36.1763万股,换手率0.18%,振幅6.56%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.28%。其相关个股中,Incannex Healthcare Inc.、Eton Pharmaceuticals, Inc.、正业生物涨幅较大,Incannex Healthcare Inc.、Petros Pharmaceuticals, Inc.、Shuttle Pharmaceuticals Holdings, Inc.较为活跃,换手率分别为1705.34%、31.09%、9.92%,振幅较大的相关个股有Incannex Healthcare Inc.、Durect Corporation、正业生物,振幅分别为279.02%、28.83%、25.37%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421485094f6cb1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421485094f6cb1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ESPR","LENZ","BK4007"],"gpt_icon":0},{"id":"2534427725","title":"Esperion Therapeutics, Inc.盘中异动 股价大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534427725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534427725?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:37","pubTimestamp":1747057061,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时37分,Esperion Therapeutics, Inc.股票出现波动,股价急速拉升5.06%。截至发稿,该股报0.839美元/股,成交量73.2257万股,换手率0.37%,振幅3.40%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.52%。其相关个股中,脑再生科技、Medicus Pharma Ltd.、坎伯兰药业涨幅较大,Shuttle Pharmaceuticals Holdings, Inc.、Petros Pharmaceuticals, Inc.、Incannex Healthcare Inc.较为活跃,换手率分别为187.68%、74.24%、6.24%,振幅较大的相关个股有Incannex Healthcare Inc.、Shuttle Pharmaceuticals Holdings, Inc.、脑再生科技,振幅分别为12.78%、9.81%、8.96%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213742a6dc51eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213742a6dc51eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","BK4539","ESPR"],"gpt_icon":0},{"id":"2534238759","title":"Esperion Therapeutics, Inc.2025财年第一财季实现净利润-40.46百万美元,同比减少166.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534238759","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534238759?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:00","pubTimestamp":1746979233,"startTime":"0","endTime":"0","summary":"5月12日,Esperion Therapeutics, Inc.公布财报,公告显示公司2025财年第一财季净利润为-40.46百万美元,同比减少166.31%;其中营业收入为65.00百万美元,同比减少52.90%,每股基本收益为-0.21美元。从资产负债表来看,Esperion Therapeutics, Inc.总负债7.50亿美元,其中短期债务1.15亿美元,资产负债比为0.44,流动比率为1.18。机构评级:截至2025年5月12日,当前有7家机构对Esperion Therapeutics, Inc.目标价做出预测,其中目标均价为5.79美元,其中最低目标价为1.50美元,最高目标价为16.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000103a6db2bd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000103a6db2bd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","LENZ"],"gpt_icon":0},{"id":"2534156416","title":"Esperion Therapeutics, Inc.盘中异动 早盘急速拉升5.16%报0.916美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534156416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534156416?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:27","pubTimestamp":1746718064,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时27分,Esperion Therapeutics, Inc.股票出现波动,股价大幅拉升5.16%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体跌幅为2.38%。其相关个股中,Alvotech C/Wts 、Emergent Biosolutions Inc.、Alvotech涨幅较大,Petros Pharmaceuticals, Inc.、Painreform Ltd.、Mira Pharmaceuticals, Inc.较为活跃,换手率分别为223.71%、149.35%、42.61%,振幅较大的相关个股有脑再生科技、Emergent Biosolutions Inc.、Alvotech C/Wts ,振幅分别为30.91%、23.42%、22.76%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。该信息摘要如下:Needham:维持Esperion Therapeutics评级,由买入调整至买入评级, 目标价由5.00美元调整至4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232744a476eb93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508232744a476eb93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2533868029","title":"Needham:维持Esperion Therapeutics评级,由买入调整至买入评级, 目标价由5.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533868029","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533868029?lang=zh_cn&edition=full","pubTime":"2025-05-07 19:11","pubTimestamp":1746616266,"startTime":"0","endTime":"0","summary":"Needham:维持Esperion Therapeutics(ESPR.US)评级,由买入调整至买入评级, 目标价由5.00美元调整至4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071915569751e068&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505071915569751e068&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","LENZ"],"gpt_icon":0},{"id":"2533455722","title":"Esperion Therapeutics, Inc.盘中异动 股价大跌5.05%报1.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533455722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533455722?lang=zh_cn&edition=full","pubTime":"2025-05-06 03:57","pubTimestamp":1746475042,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日03时57分,Esperion Therapeutics, Inc.股票出现波动,股价大幅下挫5.05%。截至发稿,该股报1.04美元/股,成交量276.278万股,换手率1.39%,振幅3.67%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.05%。其相关个股中,脑再生科技、BioCryst制药、Quantum Biopharma Ltd.涨幅较大,大自然药业、Quantum Biopharma Ltd.、Flora Growth Corp.较为活跃,换手率分别为142.83%、50.83%、13.82%,振幅较大的相关个股有脑再生科技、大自然药业、正业生物,振幅分别为66.17%、46.93%、17.52%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050603572294ed24bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050603572294ed24bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2532004995","title":"Esperion Therapeutics, Inc.盘中异动 早盘急速上涨5.06%报1.050美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532004995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532004995?lang=zh_cn&edition=full","pubTime":"2025-05-01 22:56","pubTimestamp":1746111367,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时56分,Esperion Therapeutics, Inc.股票出现波动,股价快速上涨5.06%。截至发稿,该股报1.050美元/股,成交量83.9558万股,换手率0.42%,振幅5.50%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体跌幅为4.03%。其相关个股中,脑再生科技、阿尔凯默斯、Therapeuticsmd, Inc.涨幅较大,Petros Pharmaceuticals, Inc.、Organon & Co.、大自然药业较为活跃,换手率分别为16.85%、5.26%、3.78%,振幅较大的相关个股有Petros Pharmaceuticals, Inc.、Biofrontera Inc C/Wts 27/10/2026 、脑再生科技,振幅分别为32.90%、24.81%、21.10%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501225607a6d02097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501225607a6d02097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2532609826","title":"Esperion Therapeutics, Inc.盘中异动 急速拉升5.22%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532609826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532609826?lang=zh_cn&edition=full","pubTime":"2025-05-01 03:57","pubTimestamp":1746043072,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日03时57分,Esperion Therapeutics, Inc.股票出现异动,股价大幅拉升5.22%。截至发稿,该股报1.010美元/股,成交量486.647万股,换手率2.46%,振幅7.24%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为0.81%。其相关个股中,脑再生科技、Aytu Biopharma, Inc.、Scilex Holding Company C/Wts 10/11/2027 涨幅较大,Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃,换手率分别为1159.13%、71.57%、30.76%,振幅较大的相关个股有脑再生科技、Biofrontera Inc C/Wts 27/10/2026 、Petros Pharmaceuticals, Inc.,振幅分别为103.87%、50.54%、49.23%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501035753a6cf3aac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501035753a6cf3aac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","ESPR","LENZ"],"gpt_icon":0},{"id":"2531766123","title":"Esperion Therapeutics, Inc.盘中异动 大幅拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531766123","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531766123?lang=zh_cn&edition=full","pubTime":"2025-04-30 00:35","pubTimestamp":1745944502,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日00时35分,Esperion Therapeutics, Inc.股票出现波动,股价快速拉升5.10%。截至发稿,该股报0.954美元/股,成交量83.92万股,换手率0.42%,振幅6.10%。Esperion Therapeutics, Inc.股票所在的制药行业中,整体涨幅为1.45%。其相关个股中,Kiniksa Pharmaceuticals, Ltd.、Mira Pharmaceuticals, Inc.、Cardiol Therapeutics Inc.涨幅较大,Petros Pharmaceuticals, Inc.、大自然药业、Incannex Healthcare Inc.较为活跃,换手率分别为399.76%、62.91%、51.31%,振幅较大的相关个股有正业生物、Petros Pharmaceuticals, Inc.、Scilex Holding Company,振幅分别为55.55%、38.51%、17.74%。Esperion Therapeutics, Inc.公司简介:Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003503a46c6c6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430003503a46c6c6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESPR","BK4139","LENZ","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.esperion.com","stockEarnings":[{"period":"1week","weight":-0.1534},{"period":"1month","weight":-0.0335},{"period":"3month","weight":1.063},{"period":"6month","weight":1.4069},{"period":"1year","weight":0.272},{"period":"ytd","weight":0.1159}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.257},{"period":"1year","weight":0.1629},{"period":"ytd","weight":0.1452}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Esperion Therapeutics, Inc.于2008年1月在特拉华州注册成立。该公司是一家后期制药公司,专注于开发和商业化补充,方便,具有成本效益的每日一次口服疗法,用于治疗 LDL-C升高的患者。 通过科学和临床卓越以及对胆固醇生物学的深入理解,该公司有经验的脂质管理团队致力于开发新的LDL-C降低疗法,这将对减少全球心血管疾病或心血管疾病产生重大影响; 世界各地死亡的主要原因。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.040038},{"month":2,"riseRate":0.5,"avgChangeRate":0.124334},{"month":3,"riseRate":0.5,"avgChangeRate":-0.027865},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.028114},{"month":5,"riseRate":0.666667,"avgChangeRate":-0.032489},{"month":6,"riseRate":0.75,"avgChangeRate":0.035061},{"month":7,"riseRate":0.461538,"avgChangeRate":-0.001019},{"month":8,"riseRate":0.461538,"avgChangeRate":0.026549},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.000828},{"month":10,"riseRate":0.461538,"avgChangeRate":-0.032368},{"month":11,"riseRate":0.666667,"avgChangeRate":0.13174},{"month":12,"riseRate":0.5,"avgChangeRate":0.079218}],"exchange":"NASDAQ","name":"Esperion Therapeutics Inc.","nameEN":"Esperion Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Esperion Therapeutics Inc.(ESPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Esperion Therapeutics Inc.(ESPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Esperion Therapeutics Inc.,ESPR,Esperion Therapeutics Inc.股票,Esperion Therapeutics Inc.股票老虎,Esperion Therapeutics Inc.股票老虎国际,Esperion Therapeutics Inc.行情,Esperion Therapeutics Inc.股票行情,Esperion Therapeutics Inc.股价,Esperion Therapeutics Inc.股市,Esperion Therapeutics Inc.股票价格,Esperion Therapeutics Inc.股票交易,Esperion Therapeutics Inc.股票购买,Esperion Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Esperion Therapeutics Inc.(ESPR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Esperion Therapeutics Inc.(ESPR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}